---
title: "Canaccord Genuity Remains a Buy on Enovis (ENOV)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297774100.md"
description: "Canaccord Genuity analyst Caitlin Cronin reiterated a Buy rating on Enovis yesterday and set a price target of $45.00. The company’s shares closed yesterday at $20.53. According to TipRanks, Cronin is a 4-star analyst with an average return of 9.6% and a 48.31% success rate. Enovis has an analyst consensus of Strong Buy, with a price target consensus of $39.10, which is a 90.45% upside from current levels. In a report released today, Wells Fargo also assigned a Buy rating to the stock with a $33.00 price target."
datetime: "2026-09-02T10:56:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297774100.md)
  - [en](https://longbridge.com/en/news/297774100.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297774100.md)
generator: "portal-rs"
---

# Canaccord Genuity Remains a Buy on Enovis (ENOV)

Canaccord Genuity analyst Caitlin Cronin reiterated a Buy rating on Enovis yesterday and set a price target of $45.00. The company’s shares closed yesterday at $20.53.

According to TipRanks, Cronin is a 4-star analyst with an average return of 9.6% and a 48.31% success rate.

Enovis has an analyst consensus of Strong Buy, with a price target consensus of $39.10, which is a 90.45% upside from current levels. In a report released today, Wells Fargo also assigned a Buy rating to the stock with a $33.00 price target.

### Related Stocks

- [ENOV.US](https://longbridge.com/en/quote/ENOV.US.md)
- [WFC.US](https://longbridge.com/en/quote/WFC.US.md)
- [WFC-D.US](https://longbridge.com/en/quote/WFC-D.US.md)
- [WFC-L.US](https://longbridge.com/en/quote/WFC-L.US.md)
- [WFC-Y.US](https://longbridge.com/en/quote/WFC-Y.US.md)
- [WFC-C.US](https://longbridge.com/en/quote/WFC-C.US.md)
- [WFC-Z.US](https://longbridge.com/en/quote/WFC-Z.US.md)
- [WFC-A.US](https://longbridge.com/en/quote/WFC-A.US.md)

## Related News & Research

- [Oliver Engert Buys 2,458 Shares of Enovis (NYSE:ENOV) Stock](https://longbridge.com/en/news/298087165.md)
- [Enovis CEO Damien McDonald acquires $249,620 of common shares](https://longbridge.com/en/news/298083383.md)
- [Enovis: Buy Rating Reaffirmed as Surgical Robotics Acquisition Closes Competitive Gap; Price Target Trimmed to $36 on Deal-Related Costs and Leverage](https://longbridge.com/en/news/297689580.md)
- [ENOV: Acquisition of eCential Robotics boosts robotics innovation and growth in orthopedics](https://longbridge.com/en/news/297685002.md)
- [Enovis Targets Robotic Surgery Expansion With €155M eCential Robotics Deal](https://longbridge.com/en/news/297665085.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**